CTY: CITY THERAPEUTICS, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
2 open-market buys totaling $6.12M and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 46 | CTY | CITY THERAPEUTICS, INC. | Arch Venture Partners Xii, Llc / Arch Venture Partners Xii, L.P. / Arch Venture Fund Xii, L.P. / Crandell Keith / Burow Kristina / Gillis Steven | 10% Owner | 2026-10-19 | $3.06M | 1% | 2 insiders |
| 48 | CTY | CITY THERAPEUTICS, INC. | Nelsen Robert | Director | 2026-10-19 | $3.06M | 1% | 2 insiders |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.